Rare diseases
Investigational molecules
Locations
Back to Greece8 clinical trials in Kalamata, Greece. Every trial is listed in the EU Clinical Trials Register and updated daily.
Efficacy and safety of oral semaglutide for weight loss in adults with overweight or obesity
GreecePhase 3 Study of LY4170156 (Sofetabart Mipitecan) with drug combination in platinum‑resistant and platinum‑sensitive ovarian cancer patients
GreeceStudy of Zenagamtide (NNC0487-0111) versus placebo in patients with heart failure with preserved or mildly reduced ejection fraction and obesity
GreeceComparing AZD5335 with mirvetuximab soravtansine or a drug combination in patients with platinum-resistant ovarian cancer
GreeceA study comparing BNT323 with chemotherapy in patients with HER2-expressing recurrent endometrial cancer who received previous treatment
GreeceA study comparing ziltivekimab to placebo in patients with heart failure with mildly reduced or preserved ejection fraction and inflammation
GreeceStudy on the Effectiveness of Weekly IcoSema (Insulin Icodec and Semaglutide) vs. Daily Insulin Glargine for Adults with Type 2 Diabetes Not Controlled by Oral Drugs
GreeceA Phase 3 Randomized Open-Label Study of Sacituzumab Govitecan Versus Physician's Choice in Recurrent or Persistent Endometrial Cancer Post-Chemotherapy and Immunotherapy
GreeceThe busiest research cities in the country
What the registry says about research in the country
Ongoing clinical research focusing on innovative treatment approaches for Type 2 diabetes, exploring weekly combination therapies versus traditional daily insulin treatments.
The study aims to evaluate the effectiveness of a novel weekly combination medication compared to standard daily insulin treatment, potentially offering more convenient therapeutic options for patients managing diabetes.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
